A phase II study of milataxel: a novel taxane analogue in previously treated patients with advanced colorectal cancer

被引：0
|
作者：
Ramesh K. Ramanathan
Joel Picus
Haralambos Raftopoulos
Stephen Bernard
A. Craig Lockhart
Gary Frenette
John Macdonald
Susan Melin
Daniel Berg
Frank Brescia
Howard Hochster
Allen Cohn
机构：
[1] University of Pittsburgh School of Medicine,Division of Hematology/Oncology, Department of Medicine
[2] Washington School of Medicine,Department of Internal Medicine, Division of Hematology/Oncology
[3] Columbia University Medical Center,undefined
[4] University of North Carolina,undefined
[5] Chapel Hill,undefined
[6] Vanderbilt University Medical Center,undefined
[7] Carolinas Hematology–Oncology Associates,undefined
[8] Saint Vincent’s Comprehensive Cancer Center,undefined
[9] Aptium Oncology,undefined
[10] Wake Forest University,undefined
[11] University of Iowa,undefined
[12] Medical University of South Carolina,undefined
[13] New York University School of Medicine,undefined
[14] Rocky Mountain Cancer Center,undefined
[15] UPMC Cancer Pavilion,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2008年 / 61卷
关键词：
Colorectal cancer; Phase II; Milataxel; MAC-321; Taxanes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：453 / 458
页数：5
相关论文
共 50 条
  • [1] A phase II study of milataxel: a novel taxane analogue in previously treated patients with advanced colorectal cancer
    Ramanathan, Ramesh K.
    Picus, Joel
    Raftopoulos, Haralambos
    Bernard, Stephen
    Lockhart, A. Craig
    Frenette, Gary
    Macdonald, John
    Melin, Susan
    Berg, Daniel
    Brescia, Frank
    Hochster, Howard
    Cohn, Allen
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 61 (03) : 453 - 458
  • [2] PHASE-II STUDY OF FTORAFUR IN PREVIOUSLY UNTREATED AND TREATED PATIENTS WITH ADVANCED COLORECTAL-CANCER
    SCHUTT, AJ
    HAHN, RG
    MOERTEL, CG
    OCONNELL, MJ
    RUBIN, J
    CREAGAN, ET
    CANCER TREATMENT REPORTS, 1983, 67 (05): : 505 - 506
  • [3] Phase II Study of Personalized Peptide Vaccination for Previously Treated Advanced Colorectal Cancer
    Kibe, Shiro
    Yutani, Shigeru
    Motoyama, Satoru
    Nomura, Takanobu
    Tanaka, Natsuki
    Kawahara, Akihiko
    Yamaguchi, Tomohiko
    Matsueda, Satoko
    Komatsu, Nobukazu
    Miura, Masatomo
    Hinai, Yudai
    Hattori, Satoshi
    Yamada, Akira
    Kage, Masayoshi
    Itoh, Kyogo
    Akagi, Yoshito
    Sasada, Tetsuro
    CANCER IMMUNOLOGY RESEARCH, 2014, 2 (12) : 1154 - 1162
  • [4] Phase II study of a novel taxane (Cabazitaxel-XRP 6258) in previously treated advanced non-small cell lung cancer (NSCLC) patients
    Ankit Madan
    Benjamin S. Jones
    Rodolfo Bordoni
    Mansoor N. Saleh
    Mary S. Jerome
    Deborah K. Miley
    Bradford E. Jackson
    Francisco Robert
    Cancer Chemotherapy and Pharmacology, 2016, 78 : 509 - 515
  • [5] Phase II study of a novel taxane (Cabazitaxel-XRP 6258) in previously treated advanced non-small cell lung cancer (NSCLC) patients
    Madan, Ankit
    Jones, Benjamin S.
    Bordoni, Rodolfo
    Saleh, Mansoor N.
    Jerome, Mary S.
    Miley, Deborah K.
    Jackson, Bradford E.
    Robert, Francisco
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 78 (03) : 509 - 515
  • [6] Phase II study of the novel oral Src-kinase inhibitor, AZD0530, in previously treated advanced colorectal cancer patients
    Eng, Cathy
    Kopetz, Scott
    Morris, Jeffrey
    Malik, Zulfiqar
    Stewart, David
    Chang, Hsiu-yin
    Ohinata, Aki
    Abbruzzese, James
    Gallick, Gary
    CANCER RESEARCH, 2008, 68 (09)
  • [7] A phase II study of marimastat in patients with previously treated advanced lung cancer.
    Nakagawa, K
    Fukuoka, M
    CLINICAL CANCER RESEARCH, 1999, 5 : 3774S - 3774S
  • [8] Tallimustine in advanced previously untreated colorectal cancer, a phase II study
    Punt, CJA
    Humblet, Y
    Roca, E
    Dirix, LY
    Wainstein, R
    Polli, A
    Corradino, I
    BRITISH JOURNAL OF CANCER, 1996, 73 (06) : 803 - 804
  • [9] Phase II Clinical and Pharmacokinetic Study of Aflibercept in Patients with Previously Treated Metastatic Colorectal Cancer
    Tang, Patricia A.
    Cohen, Steven J.
    Kollmannsberger, Christian
    Bjarnason, Georg
    Virik, Kiran
    MacKenzie, Mary J.
    Lourenco, Lillian
    Wang, Lisa
    Chen, Alice
    Moore, Malcolm J.
    CLINICAL CANCER RESEARCH, 2012, 18 (21) : 6023 - 6031
  • [10] Phase II study of capecitabine, oxaliplatin, and erlotinib in previously treated patients with metastastic colorectal cancer
    Meyerhardt, JA
    Zhu, AX
    Enzinger, PC
    Ryan, DP
    Clark, JW
    Kulke, MH
    Earle, CC
    Vincitore, M
    Michelini, A
    Sheehan, S
    Fuchs, CS
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (12) : 1892 - 1897
12345